Racial and Socioeconomic Equity of Tecovirimat Treatment during the 2022 Mpox Emergency, New York, New York, USA

Racial and Socioeconomic Equity of Tecovirimat Treatment during the 2022 Mpox Emergency, New York, New York, USA

We assessed tecovirimat treatment equity for 3,740 mpox patients in New York, New York, USA, during the 2022 mpox emergency; 32.4% received tecovirimat. Treatment rates by race/ethnicity were 38.8% (White), 31.3% (Black/African American), 31.0% (Hispanic/Latino), and 30.1% (Asian/Pacific Islander/o...

Full description

Bibliographic Details
Main Authors: Maura K. Lash, Ned H. Latham, Pui Ying Chan, Mary M.K. Foote, Elizabeth A. Garcia, Matthew F. Silverstein, Marcia Wong, Mark Alexander, Karen A. Alroy, Lovedeep Bajaj, Kuan Chen, James Steele Howard, Lucretia E. Jones, Ellen H. Lee, Julian L. Watkins, Tristan D. McPherson
Format: Article
Language:English
Published: Centers for Disease Control and Prevention 2023-11-01
Series:Emerging Infectious Diseases
Subjects:
mpox
health equity
racism
tecovirimat
emergencies
sexually transmitted infections
Online Access:https://wwwnc.cdc.gov/eid/article/29/11/23-0814_article

Internet

https://wwwnc.cdc.gov/eid/article/29/11/23-0814_article

Similar Items